2022 - Research.com Microbiology in Japan Leader Award
Hiromitsu Kumada mostly deals with Internal medicine, Gastroenterology, Virology, Hepatocellular carcinoma and Hepatitis C virus. His Internal medicine study frequently draws connections between related disciplines such as Immunology. His Gastroenterology research also works with subjects such as
His Virology course of study focuses on Genotype and Drug resistance and Polymerase chain reaction. His research in Hepatocellular carcinoma intersects with topics in Cancer, Carcinoma, Retrospective cohort study and Oncology. He studied Hepatitis C and Ribavirin that intersect with Combination therapy, Viral load and Anemia.
Hiromitsu Kumada focuses on Internal medicine, Gastroenterology, Virology, Hepatocellular carcinoma and Hepatitis C virus. His Internal medicine research integrates issues from Ribavirin and Immunology. His Gastroenterology research includes themes of Chronic hepatitis, Adverse effect and Surgery, Retrospective cohort study.
Many of his studies on Virology involve topics that are commonly interrelated, such as Genotype. The Hepatocellular carcinoma study combines topics in areas such as Carcinoma, Radiology, Oncology and Hazard ratio. His Hepatitis C virus research includes elements of Interferon, Alpha interferon and Viral load.
His scientific interests lie mostly in Internal medicine, Gastroenterology, Hepatocellular carcinoma, Hepatitis C virus and Virology. His work focuses on many connections between Internal medicine and other disciplines, such as Genotype, that overlap with his field of interest in Young adult. His biological study spans a wide range of topics, including Regimen, Retrospective cohort study, Nonalcoholic fatty liver disease, Fatty liver and Hepatitis B virus.
His work carried out in the field of Regimen brings together such families of science as Pibrentasvir, Immunology and Glecaprevir. His studies deal with areas such as Multivariate analysis, Oncology and Hazard ratio as well as Hepatocellular carcinoma. His works in Asunaprevir and Ribavirin are all subjects of inquiry into Virology.
The scientist’s investigation covers issues in Internal medicine, Gastroenterology, Hepatocellular carcinoma, Daclatasvir and Adverse effect. His Internal medicine study integrates concerns from other disciplines, such as Surgery, Glecaprevir and Hepatitis C virus. He combines subjects such as Clinical trial and Viral load with his study of Hepatitis C virus.
His Gastroenterology research is multidisciplinary, relying on both Pibrentasvir, Tolerability, HBeAg, Type 2 Diabetes Mellitus and Cohort. His Hepatocellular carcinoma research incorporates elements of Retrospective cohort study, Carcinoma, Oncology and Hazard ratio. His Daclatasvir research is multidisciplinary, incorporating perspectives in NS5A and Asunaprevir.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma
Yujin Hoshida;Augusto Villanueva;Masahiro Kobayashi;Judit Peix.
Integrative transcriptome analysis reveals common molecular subclasses of human hepatocellular carcinoma.
Yujin Hoshida;Sebastian M.B. Nijman;Sebastian M.B. Nijman;Masahiro Kobayashi;Jennifer A. Chan;Jennifer A. Chan.
Cancer Research (2009)
The long-term pathological evolution of chronic hepatitis C
M Yano;H Kumada;M Kage;K Ikeda.
Long‐term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection
Tetsuya Hosaka;Fumitaka Suzuki;Masahiro Kobayashi;Yuya Seko.
Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: A long-term observation study of 1,643 patients using statistical bias correction with proportional hazard analysis.
Kenji Ikeda;Satoshi Saitoh;Yasuji Arase;Kazuaki Chayama.
Daclatasvir plus asunaprevir for chronic HCV genotype 1b infection.
Hiromitsu Kumada;Yoshiyuki Suzuki;Kenji Ikeda;Joji Toyota.
Effects of Oral Branched-Chain Amino Acid Granules on Event-Free Survival in Patients With Liver Cirrhosis
Yasutoshi Muto;Shunichi Sato;Akiharu Watanabe;Hisataka Moriwaki.
Clinical Gastroenterology and Hepatology (2005)
Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: a prospective observation of 2215 patients
Kenji Ikeda;Satoshi Saitoh;Yoshiyuki Suzuki;Masahiro Kobayashi.
Journal of Hepatology (1998)
Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma.
Masatoshi Kudo;Kazuho Imanaka;Nobuyuki Chida;Kohei Nakachi.
European Journal of Cancer (2011)
A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians
Yoichiro Kamatani;Sukanya Wattanapokayakit;Hidenori Ochi;Takahisa Kawaguchi.
Nature Genetics (2009)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: